Synopsis A recent clinical study demonstrates that MRI texture analysis can predict the risk of tumor recurrence or progression in patients with Non-Functioning Pituitary Adenomas (NFPAs). The present study aims to hypothesize that MRI texture analysis may predict tumor recurrence or progression in patients with NFPAs undergoing transsphenoidal pituitary surgery (TSS). This week’s “MED FACT” discusses a clinical trial from European Society of Endocrinology, “MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas” . July 4, 2018. Authors : Brandon P Galm; E.
Leonardo Martinez-Salazar; Brooke Swearingen; et. al. Key Takeaways: MRI texture analysis can predict the risk of tumor recurrence or progression in patients with NFPAs. Objective: To determine MRI texture analysis can predict recurrence or progression of…